Literature DB >> 8281955

Alterations in the extracellular matrix of the myocardium in essential hypertension.

F J Pardo Mindán1, A Panizo.   

Abstract

Hypertension produces myocyte hypertrophy and increases the extracellular matrix. In order to determine the composition of the extracellular matrix we studied the hearts from 14 hypertensive patients by immunohistochemistry using antibodies against collagen I, III, IV and V, fibronectin, myoglobin, muscular specific actin, Factor VIII, CD 34 and vimentin. The myocardium showed a focal increase in fibronectin, collagen I and III and diffuse deposition of laminin, collagen IV and V. Cells positive for vimentin, Factor VIII and CD 34 were also increased, but with considerable variation from case to case. We found no relation between matrix variation and the degree of hypertension or the time elapsed from the beginning of the disease. We conclude that the main role of the matrix in hypertension may be remodelling of the heart so that it entraps muscle fibres and increases their contractility.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8281955

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  13 in total

1.  Interstitial fibrosis in the dilated non-ischaemic myocardium.

Authors:  A Brooks; V Schinde; A C Bateman; P J Gallagher
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

2.  Post-mortem evidence of idiopathic left ventricular hypertrophy and idiopathic interstitial myocardial fibrosis: is exercise the cause?

Authors:  Gregory Whyte; Mary Sheppard; Keith George; Robert Shave; Sanjay Prasad; Rory O'Hanlon; Sanjay Sharma
Journal:  BMJ Case Rep       Date:  2009-02-02

3.  An updated concept for left ventricular hypertrophy risk in hypertension.

Authors:  Edward D Frohlich
Journal:  Ochsner J       Date:  2009

4.  Long-term effect of N-acetyl-seryl-aspartyl-lysyl-proline on left ventricular collagen deposition in rats with 2-kidney, 1-clip hypertension.

Authors:  N E Rhaleb; H Peng; X P Yang; Y H Liu; D Mehta; E Ezan; O A Carretero
Journal:  Circulation       Date:  2001-06-26       Impact factor: 29.690

5.  Myocardial fibrosis in an veteran endurance athlete.

Authors:  Mathew Wilson; Rory O'Hanlon; Sanjay Prasad; Sandeep Basavarajaiah; Nigel Stephens; Roxy Senior; Anthony Shaw; Sanjay Sharma; Gregory Whyte
Journal:  BMJ Case Rep       Date:  2009-08-17

Review 6.  Cardiovascular function and the veteran athlete.

Authors:  M Wilson; R O'Hanlon; S Basavarajaiah; K George; D Green; P Ainslie; S Sharma; S Prasad; C Murrell; D Thijssen; A Nevill; G Whyte
Journal:  Eur J Appl Physiol       Date:  2010-06-17       Impact factor: 3.078

Review 7.  [Cardiac sequelae of hypertension].

Authors:  M Steinmetz; G Nickenig
Journal:  Internist (Berl)       Date:  2009-04       Impact factor: 0.743

Review 8.  Myocardial T1 mapping: modalities and clinical applications.

Authors:  Christine L Jellis; Deborah H Kwon
Journal:  Cardiovasc Diagn Ther       Date:  2014-04

9.  Mechanical stimuli for left ventricular growth during pressure overload.

Authors:  J Mojumder; J S Choy; S Leng; L Zhong; G S Kassab; L C Lee
Journal:  Exp Mech       Date:  2020-08-11       Impact factor: 2.808

10.  Proteoglycan Remodeling Is Accelerated in Females with Angina Pectoris and Diffuse Myocardial Fibrosis: the iPOWER Study.

Authors:  Naja Dam Mygind; Signe Holm Nielsen; Marie Mide Michelsen; Adam Pena; Daria Frestad Bechsgaard; Elena Suhrs; Kira Bang Bove; Federica Genovese; Henning Bay Nielsen; Morten Karsdal; Niels Vejlstrup; Eva Prescott; Jens Kastrup
Journal:  J Cardiovasc Transl Res       Date:  2021-03-01       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.